Tsp Capital Management Group, LLC Celldex Therapeutics, Inc. Transaction History
Tsp Capital Management Group, LLC
- $348 Million
- Q3 2025
A detailed history of Tsp Capital Management Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tsp Capital Management Group, LLC holds 375,927 shares of CLDX stock, worth $9.6 Million. This represents 2.8% of its overall portfolio holdings.
Number of Shares
375,927
Previous 371,427
1.21%
Holding current value
$9.6 Million
Previous $7.56 Million
28.67%
% of portfolio
2.8%
Previous 2.58%
Shares
26 transactions
Others Institutions Holding CLDX
# of Institutions
206Shares Held
66.8MCall Options Held
222KPut Options Held
234K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$156 Million13.34% of portfolio
-
Wellington Management Group LLP Boston, MA5.8MShares$148 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.95MShares$101 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.89MShares$99.5 Million0.2% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.2B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...